0,967  0,001  Antimutagenic
0,874  0,005  Cyclophilin D inhibitor
0,874  0,005  Antidiabetic
0,873  0,004  Mutagenic
0,871  0,003  UGT1A9 substrate
0,862  0,004  Cytostatic
0,857  0,005  Caspase 9 stimulant
0,855  0,003  Genotoxic
0,823  0,004  NOS2 expression inhibitor
0,792  0,002  Amylase inhibitor
0,783  0,003  UGT1A1 substrate
0,786  0,018  Apoptosis agonist
0,746  0,008  Chemopreventive
0,740  0,003  Glutathione S-transferase substrate
0,753  0,016  Transcription factor NF kappa B inhibitor
0,696  0,013  Antileukemic
0,685  0,005  Hypoglycemic
0,684  0,009  Sensitization
0,676  0,007  Antioxidant
0,667  0,003  UGT2B1 substrate
0,662  0,004  NOS3 expression enhancer
0,655  0,013  Chemoprotective
0,674  0,036  Antiinflammatory
0,643  0,013  Cholesterol antagonist
0,638  0,014  Antibacterial
0,627  0,016  Carcinogenic
0,610  0,009  Apoptosis antagonist
0,594  0,005  Antihypertriglyceridemic
0,590  0,008  DNA synthesis inhibitor
0,586  0,005  Monophenol monooxygenase inhibitor
0,603  0,022  Alzheimer's disease treatment
0,588  0,009  Free radical scavenger
0,596  0,017  Antihypercholesterolemic
0,581  0,014  Cytotoxic
0,580  0,015  Antineoplastic (cervical cancer)
0,572  0,013  Cardioprotectant
0,580  0,029  TNF expression inhibitor
0,555  0,014  AR expression inhibitor
0,549  0,012  Metabolic disease treatment
0,569  0,040  Antineoplastic (breast cancer)
0,556  0,027  Teratogen
0,544  0,015  NOS3 expression inhibitor
0,560  0,036  Antineoplastic (lung cancer)
0,531  0,012  Vasodilator, coronary
0,529  0,012  DNA damaging
0,525  0,008  UGT2B4 substrate
0,522  0,006  Melanin inhibitor
0,571  0,060  Alpha-glucosidase inhibitor
0,526  0,017  Proliferative diseases treatment
0,515  0,006  Skin whitener
0,527  0,019  CTGF expression inhibitor
0,514  0,015  Nitric oxide antagonist
0,524  0,027  Immunosuppressant
0,524  0,028  Embryotoxic
0,508  0,016  Antidiabetic (type 2)
0,502  0,016  Antiamyloidogenic
0,490  0,012  UDP-glucuronosyltransferase substrate
0,491  0,013  UGT1A6 substrate
0,481  0,004  Topoisomerase I inhibitor
0,492  0,016  Antiparasitic
0,504  0,035  Antineoplastic (colorectal cancer)
0,476  0,007  Topoisomerase II inhibitor
0,480  0,011  Antihypoxic
0,481  0,015  Antineoplastic (lymphoma)
0,473  0,014  Antineoplastic (osteosarcoma)
0,474  0,017  Amyloid beta aggregation inhibitor
0,481  0,025  Hepatic disorders treatment
0,465  0,010  Antineoplastic (small cell lung cancer)
0,466  0,013  RNA-directed DNA polymerase inhibitor
0,475  0,024  Caspase 3 stimulant
0,484  0,036  Antineoplastic (colon cancer)
0,450  0,005  Aldehyde dehydrogenase inhibitor
0,464  0,018  Antipyretic
0,477  0,032  Antithrombotic
0,451  0,006  Sulfotransferase substrate
0,461  0,020  ICAM1 expression inhibitor
0,460  0,026  Antiosteoporotic
0,467  0,033  Bone diseases treatment
0,457  0,026  Antineoplastic (brain cancer)
0,471  0,042  Antipruritic, allergic
0,458  0,030  Antifungal
0,460  0,037  Stroke treatment
0,449  0,028  Antineoplastic (glioma)
0,425  0,007  Alkylator
0,424  0,007  UGT2B15 substrate
0,422  0,005  UDP-glucose 4-epimerase inhibitor
0,463  0,048  CYP3A4 substrate
0,429  0,015  Interleukin agonist
0,430  0,020  Interleukin 2 agonist
0,441  0,036  Antineoplastic (ovarian cancer)
0,409  0,008  Protein kinase stimulant
0,423  0,024  Antineoplastic (glioblastoma multiforme)
0,401  0,005  Neurotrophic factor enhancer
0,432  0,039  Respiratory analeptic
0,402  0,011  Interferon gamma antagonist
0,442  0,050  CYP2C9 substrate
0,402  0,013  Hepatoprotectant
0,398  0,011  Antiviral (Influenza)
0,428  0,042  Immunostimulant
0,406  0,021  Angiogenesis stimulant
0,394  0,012  Antihypotensive
0,416  0,035  Radioprotector
0,433  0,054  Antiobesity
0,389  0,017  Antihelmintic
0,382  0,011  Antialcoholic
0,399  0,030  Hypoxia-inducible factor 1 alpha inhibitor
0,404  0,038  Lipoprotein disorders treatment
0,389  0,025  Vasodilator
0,412  0,052  Vasodilator, peripheral
0,410  0,050  Prostate cancer treatment
0,378  0,018  UGT1A4 substrate
0,393  0,040  Antineoplastic (pancreatic cancer)
0,359  0,005  Antihemorrhagic
0,368  0,017  Antiviral (Herpes)
0,359  0,016  UGT2B7 substrate
0,349  0,007  Antifungal enhancer
0,354  0,012  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,345  0,006  Aldose reductase substrate
0,357  0,023  Antineoplastic (sarcoma)
0,345  0,013  Lipid peroxidase inhibitor
0,357  0,027  Antineoplastic (lymphocytic leukemia)
0,345  0,015  Carcinogenic, group 3
0,338  0,010  Antidiabetic (type 1)
0,340  0,012  Antiviral (Influenza A)
0,363  0,037  Radiosensitizer
0,340  0,016  UGT1A3 substrate
0,342  0,021  Platelet adhesion inhibitor
0,368  0,048  Antineoplastic (melanoma)
0,337  0,017  VCAM1 expression inhibitor
0,351  0,036  Antidiabetic symptomatic
0,355  0,042  Antineoplastic (non-small cell lung cancer)
0,318  0,005  AMP-activated protein kinase stimulant
0,363  0,051  Antimycobacterial
0,359  0,048  Analeptic
0,317  0,008  Expectorant
0,321  0,014  Diabetic nephropathy treatment
0,316  0,012  Adenylate cyclase inhibitor
0,322  0,019  Antipruritic, non-allergic
0,354  0,056  5 Hydroxytryptamine release stimulant
0,307  0,009  Cystathionine beta-synthase inhibitor
0,382  0,085  Histamine release inhibitor
0,354  0,058  Immunomodulator
0,332  0,039  Antineoplastic (liver cancer)
0,297  0,011  Hexokinase inhibitor
0,306  0,023  Peptidyltransferase inhibitor
0,325  0,048  Antineoplastic (endocrine cancer)
0,290  0,015  Antineoplastic antimetabolite
0,287  0,014  Insulin secretagoues
0,275  0,005  Antiviral (Influenza B)
0,280  0,011  Antineoplastic antibiotic
0,270  0,010  Xanthine oxidase inhibitor
0,265  0,007  Selectin antagonist
0,280  0,023  Antihelmintic (Nematodes)
0,301  0,049  Hypolipemic
0,299  0,052  Antineoplastic (renal cancer)
0,270  0,027  Antiviral (Hepatitis)
0,296  0,055  Antiprotozoal (Leishmania)
0,252  0,015  Antitussive
0,246  0,010  Carbonic anhydrase III inhibitor
0,335  0,100  CYP2C19 inhibitor
0,256  0,024  Phospholipase C inhibitor
0,249  0,016  DNA intercalator
0,299  0,068  CYP1A2 substrate
0,281  0,058  Vascular (periferal) disease treatment
0,234  0,014  Antiviral (Poxvirus)
0,290  0,071  CYP2C19 substrate
0,354  0,136  Antineoplastic (solid tumors)
0,231  0,014  Antirickettsial
0,223  0,007  Carcinogenic, group 2A
0,226  0,010  Antineoplastic, alkylator
0,239  0,025  Antiviral (Hepatitis C)
0,215  0,001  Sodium/glucose cotransporter inhibitor
0,245  0,032  Protein-tyrosine phosphatase inhibitor
0,237  0,025  Alpha-N-acetylglucosaminidase inhibitor
0,242  0,032  Antineoplastic (squamous cell carcinoma)
0,230  0,020  UGT2B10 substrate
0,222  0,012  Topoisomerase II alpha inhibitor
0,248  0,042  P-glycoprotein inhibitor
0,267  0,065  Antineoplastic (bladder cancer)
0,296  0,096  Calcium channel activator
0,207  0,008  DNA repair enzyme inhibitor
0,271  0,073  GST M1-1 substrate
0,208  0,010  Adenylate cyclase stimulant
0,209  0,017  CF transmembrane conductance regulator agonist
0,309  0,118  Antiprotozoal
0,217  0,027  Carcinogenic, group 1
0,220  0,032  Antidote
0,212  0,025  DNA polymerase I inhibitor
0,200  0,014  Antispirochetal
0,197  0,013  Antibiotic
0,198  0,014  Carbonic anhydrase XIII inhibitor
0,208  0,027  SULT1A3 substrate
0,229  0,048  Insulin sensitizer
0,241  0,060  Antiviral (HIV)
0,243  0,067  Cyclic AMP phosphodiesterase inhibitor
0,184  0,017  Photosensitizer
0,254  0,088  Antituberculosic
0,193  0,027  Toll-Like receptor 2 antagonist
0,178  0,013  NADH dehydrogenase inhibitor
0,179  0,014  Triose-phosphate isomerase inhibitor
0,182  0,018  Mucolytic
0,186  0,023  Microtubule formation inhibitor
0,193  0,031  Protein-tyrosine phosphatase 1B inhibitor
0,214  0,052  Diabetic retinopathy treatment
0,185  0,025  Carcinogenic, group 2B
0,175  0,016  Carbonic anhydrase VI inhibitor
0,168  0,013  Thioredoxin inhibitor
0,171  0,018  Uric acid excretion stimulant
0,190  0,037  Antiprotozoal (Coccidial)
0,167  0,015  Phosphofructokinase-1 inhibitor
0,154  0,002  Sodium/glucose cotransporter 1 inhibitor
0,151  0,001  Sodium/glucose cotransporter 2 inhibitor
0,231  0,081  Platelet antagonist
0,272  0,127  GST A substrate
0,185  0,039  Mannose-6-phosphate isomerase inhibitor
0,152  0,007  Antiviral (Dengue virus)
0,164  0,023  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,157  0,017  NAD(P)H dehydrogenase (quinone) inhibitor
0,199  0,062  Antiviral (Ebola)
0,187  0,049  Antineoplastic (carcinoma)
0,194  0,057  Antineoplastic (gastric cancer)
0,144  0,008  Phosphorylase inhibitor
0,210  0,074  Nitric-oxide synthase stimulant
0,169  0,035  Interleukin 4 antagonist
0,158  0,026  HDL-cholesterol increasing
0,142  0,011  Thioredoxin reductase inhibitor
0,147  0,016  UGT2B11 substrate
0,181  0,050  UGT2B9 substrate
0,159  0,029  Alcohol dehydrogenase substrate
0,165  0,036  Cyclooxygenase 3 inhibitor
0,152  0,023  Estrogen antagonist
0,261  0,133  Ulceration
0,156  0,030  Ca2+-transporting ATPase inhibitor
0,132  0,006  Antimycoplasmal
0,157  0,032  SULT1A1 substrate
0,141  0,022  Aminoacyl-tRNA synthetase inhibitor
0,180  0,062  Antineoplastic (bone cancer)
0,142  0,026  Toll-Like receptor 4 antagonist
0,135  0,019  Transcription factor NF kappa B stimulant
0,169  0,054  Antidiarrheal
0,191  0,081  Septic shock treatment
0,262  0,153  Atherosclerosis treatment
0,123  0,014  Na+ K+ transporting ATPase inhibitor
0,129  0,020  Glutamate dehydrogenase inhibitor
0,168  0,060  Acute respiratory distress syndrome (ARDS) treatment
0,151  0,043  Heat shock protein 70 antagonist
0,131  0,027  Actinic keratosis treatment
0,206  0,104  Myocardial infarction treatment
0,131  0,030  Anabolic
0,146  0,047  Cholesterol synthesis inhibitor
0,121  0,021  Keratolytic
0,165  0,067  Uterine stimulant
0,143  0,046  Growth stimulant
0,124  0,027  SULT1E1 substrate
0,150  0,056  Psychosexual dysfunction treatment
0,122  0,030  Estrogen receptor beta antagonist
0,129  0,037  Chronic obstructive bronchitis treatment
0,198  0,106  Aldehyde oxidase inhibitor
0,217  0,126  Antineoplastic (multiple myeloma)
0,105  0,015  Anticholelithogenic
0,099  0,009  Topoisomerase II beta inhibitor
0,150  0,061  Antiacne
0,139  0,051  Vanilloid 1 agonist
0,095  0,007  Alpha-mannosidase inhibitor
0,238  0,150  Antiprotozoal (Plasmodium)
0,271  0,184  Calcium channel L-type activator
0,108  0,024  CDC25A inhibitor
0,150  0,066  Cell wall synthesis inhibitor
0,136  0,055  Cell adhesion inhibitor
0,244  0,163  Antineoplastic (non-Hodgkin's lymphoma)
0,123  0,043  Beta glucuronidase inhibitor
0,098  0,018  Estrogen agonist
0,087  0,007  Mannosidase inhibitor
0,110  0,030  Glutamate release inhibitor
0,134  0,055  Antineoplastic (uterine cancer)
0,128  0,051  Constipation treatment
0,210  0,133  CYP2D6 substrate
0,117  0,041  HIV-1 integrase (Overall Integration) inhibitor
0,101  0,026  HIV-1 integrase (3'-Processing) inhibitor
0,197  0,123  Antiviral (West Nile virus)
0,196  0,123  Spasmolytic
0,103  0,030  Glycine receptor antagonist
0,077  0,004  Protein 30S ribosomal subunit inhibitor
0,172  0,099  DNA methylase inhibitor
0,150  0,079  Eye irritation, high
0,085  0,015  Antibiotic Glycopeptide-like
0,074  0,005  Nucleoside transporters inhibitor
0,117  0,049  Carbonic anhydrase XV inhibitor
0,088  0,021  Aldose reductase inhibitor
0,070  0,004  Cholesterol absorption inhibitor
0,091  0,026  HIV-1 integrase (Strand Transfer) inhibitor
0,117  0,052  Electron transport complex I inhibitor
0,118  0,053  Gout treatment
0,080  0,016  Glucosylceramidase inhibitor
0,151  0,088  Arachidonic acid antagonist
0,202  0,140  Antiischemic
0,100  0,039  Antiviral (Trachoma)
0,072  0,012  Glucose-6-phosphate isomerase inhibitor
0,117  0,057  Chelator
0,151  0,092  Liver fibrosis treatment
0,182  0,125  Tumour necrosis factor alpha release inhibitor
0,091  0,034  Estrogen receptor alpha antagonist
0,077  0,021  Protein 50S ribosomal subunit inhibitor
0,086  0,030  Antitreponemal
0,121  0,066  Beta amyloid protein antagonist
0,066  0,013  Equilibrative nucleoside transport protein inhibitor
0,062  0,008  Antibiotic Aminoglycoside-like
0,121  0,070  Antiviral (Hepatitis B)
0,060  0,011  Guanylate cyclase inhibitor
0,182  0,136  Antiprotozoal (Trypanosoma)
0,109  0,063  Choleretic
0,070  0,025  Mannitol-1-phosphate 5-dehydrogenase inhibitor
0,076  0,032  CDC25B inhibitor
0,084  0,040  Histidine decarboxylase inhibitor
0,062  0,019  Adenosine deaminase inhibitor
0,072  0,029  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,205  0,164  Angiogenesis inhibitor
0,154  0,114  Cardiodepressant
0,081  0,042  Lipase inhibitor
0,062  0,024  Antimetabolite
0,105  0,069  Skin irritative effect
0,087  0,051  Antiprotozoal activity enhancer
0,073  0,038  Gaucher disease treatment
0,090  0,055  ATPase (Vacuolar H+) inhibitor
0,064  0,030  Postmenopausal disorders treatment
0,148  0,114  LDLR expression enhancer
0,144  0,111  ATPase inhibitor
0,152  0,119  Antimitotic
0,058  0,026  Heparanase inhibitor
0,038  0,006  Dopamine D1 agonist
0,114  0,081  Antifungal (Pneumocystis)
0,048  0,016  Inosine monophosphate dehydrogenase inhibitor
0,081  0,051  Interferon agonist
0,071  0,043  Leukotriene synthesis inhibitor
0,078  0,051  Narcotic antagonist
0,184  0,158  Transcription factor STAT3 inhibitor
0,029  0,004  Antibiotic Anthracycline-like
0,127  0,103  Thrombolytic
0,032  0,008  Vanilloid 2 agonist
0,076  0,052  SULT1A2 substrate
0,058  0,035  Protein kinase C eta inhibitor
0,063  0,040  Purinergic P2X1 antagonist
0,059  0,037  Lipocortins synthesis agonist
0,031  0,011  Adenosine A1 receptor agonist
0,041  0,021  Estrogen receptor beta agonist
0,049  0,029  Microtubule stabilization
0,038  0,018  Purinergic P2Y2 antagonist
0,034  0,015  Uridine phosphorylase inhibitor
0,057  0,039  Postcoital contraceptive
0,038  0,020  Ceramide glucosyltransferase inhibitor
0,039  0,021  Estrogen receptor alpha agonist
0,091  0,074  Bronchodilator
0,060  0,043  Antidote, heavy metal
0,133  0,116  Dual specificity phosphatase inhibitor
0,089  0,073  Sphingomyelinase inhibitor
0,020  0,004  Antibiotic Tetracycline-like
0,179  0,164  Lipoxygenase inhibitor
0,021  0,006  Telomerase stimulant
0,201  0,186  Sodium/bile acid cotransporter inhibitor
0,025  0,011  Inosine monophosphate dehydrogenase 1 inhibitor
0,185  0,172  Gastrin inhibitor
0,093  0,080  Adenylate kinase inhibitor
0,085  0,072  Alcohol dehydrogenase inhibitor
0,024  0,013  Isoleucine-tRNA ligase inhibitor
0,137  0,128  Anesthetic general
0,111  0,102  Histone deacetylase SIRT1 inhibitor
0,178  0,170  Transcription factor STAT inhibitor
0,033  0,026  Tubulin agonist
0,049  0,041  Glucose-6-phosphate translocase inhibitor
0,050  0,043  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,154  0,147  Antineoplastic enhancer
0,060  0,053  Interferon inducer
0,039  0,033  Thymidine kinase inhibitor
0,120  0,114  Hemostatic
0,123  0,118  Antifungal (Cryptococcus)
0,102  0,098  Cyclooxygenase 1 inhibitor
0,027  0,024  1,3-Beta-glucan synthase inhibitor
0,011  0,007  Purinergic P2Y2 agonist
0,014  0,011  Adenosine A2b receptor agonist
0,029  0,027  ATP citrate lysase inhibitor
0,221  0,220  Antineoplastic (myeloid leukemia)
0,015  0,015  Adenosine A3 receptor agonist
0,046  0,046  Alpha tubulin antagonist

